Latest Method: GlucoCEST to Diagnose Cancer

Diagnose-CancerThe UK researchers have developed a new imaging technique to detect and monitor cancer in future. Through this technique, they will use non-radioactive glucose, which will help identify tumors in human body. It will be quite a simpler and cheaper process.

As published today in Nature Medicine, the research has been successfully worked out on mice. Researchers also find it helpful for distinguishing different types of tumors.

It was believed more than normal tissues, it was glucose, to which tumors respond, a better way. Therefore, a team of researchers from the University College London have developed this method, glucoCEST, in which they have used glucose rather than normal tissues and magnetic resonance imaging (MRI) instead of positron emission tomography (PET). Main idea is to scan the tumor in such a way that they could easily envisage the glucose uptake.

Similar to the existing gold standard techniques, this technique is equally responsive.

As written by the authors: "Raised glucose uptake is a hallmark of solid tumors, and its noninvasive assessment would be of key importance in the clinic, with potential applications that include tumour detection, monitoring tumour progression and evaluating response to therapy".

After assessing the results, it has been revealed that it is equally beneficial and a cost-effective method.